SEPHS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.848800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.563200E-01
Normal-vs-Stage2
7.600000E-01
Normal-vs-Stage3
5.326600E-01
Normal-vs-Stage4
3.296800E-01
Stage1-vs-Stage2
1.345400E-01
Stage1-vs-Stage3
1.798200E-01
Stage1-vs-Stage4
9.288600E-01
Stage2-vs-Stage3
6.039400E-01
Stage2-vs-Stage4
1.843220E-01
Stage3-vs-Stage4
1.695590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.071600E-01
Normal-vs-AfricanAmerican
7.917200E-01
Normal-vs-Asian
5.463000E-01
Caucasian-vs-AfricanAmerican
6.041800E-01
Caucasian-vs-Asian
2.058800E-01
AfricanAmerican-vs-Asian
3.001200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.771200E-01
Normal-vs-Female
9.895600E-01
Male-vs-Female
2.932000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.593200E-01
Normal-vs-Age(41-60Yrs)
9.425600E-01
Normal-vs-Age(61-80Yrs)
8.203200E-01
Normal-vs-Age(81-100Yrs)
6.840600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.328800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.569200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.811000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.862200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.689600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.867600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.878800E-01
Normal-vs-Daily Drinker
4.114400E-01
Normal-vs-Weekly Drinker
6.570800E-01
Normal-vs-Occasional Drinker
7.978400E-01
Normal-vs-Social Drinker
8.950000E-01
Non Drinker-vs-Daily Drinker
5.324000E-01
Non Drinker-vs-Weekly Drinker
9.692400E-01
Non Drinker-vs-Occasional Drinker
2.618200E-01
Non Drinker-vs-Social Drinker
5.802400E-01
Daily Drinker-vs-Weekly Drinker
5.316400E-01
Daily Drinker-vs-Occasional Drinker
1.339800E-01
Daily Drinker-vs-Social Drinker
2.380600E-01
Weekly Drinker-vs-Occasional Drinker
2.902000E-01
Weekly Drinker-vs-Social Drinker
6.202400E-01
Occasional Drinker-vs-Social Drinker
4.760600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.303400E-01
Normal-vs-Grade 2
1.085850E-02
Normal-vs-Grade 3
4.452100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.622200E-01
Grade 1-vs-Grade 3
5.826200E-01
Grade 1-vs-Grade 4
1.303400E-01
Grade 2-vs-Grade 3
6.079400E-01
Grade 2-vs-Grade 4
1.085850E-02
Grade 3-vs-Grade 4
4.452100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.740200E-01
Normal-vs-NonDiabetic
8.567000E-01
Diabetic-vs-NonDiabetic
4.005800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.605000E-01
Normal-vs-NoPancreatitis
8.696400E-01
Pancreatitis-vs-NoPancreatitis
3.327200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.639600E-01
Normal-vs-N1
8.441400E-01
N0-vs-N1
6.892400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.370200E-01
Normal-vs-TP53-NonMutant
8.057200E-01
TP53-Mutant-vs-TP53-NonMutant
7.664600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
